BIOGEN INC. financial data

Symbol
BIIB on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 30 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 185% % 1.9%
Quick Ratio 53% % -19%
Return On Equity 9% % -11%
Return On Assets 6% % -4.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 146,702,272 shares 0.68%
Common Stock, Shares, Outstanding 145,800,000 shares 0.62%
Entity Public Float $33,709,755,067 USD -18%
Common Stock, Value, Issued $100,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 146,600,000 shares 0.62%
Weighted Average Number of Shares Outstanding, Diluted 147,100,000 shares 0.68%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $10,065,900,000 USD 4.8%
Costs and Expenses $8,161,900,000 USD 6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $557,300,000 USD 24%
Income Tax Expense (Benefit) $295,500,000 USD 1.3%
Net Income (Loss) Attributable to Parent $1,608,500,000 USD -0.42%
Earnings Per Share, Basic 10 USD/shares -1.1%
Earnings Per Share, Diluted 10 USD/shares -0.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current $1,404,800,000 USD -16%
Inventory, Net $2,209,400,000 USD -11%
Other Assets, Current $916,800,000 USD 36%
Assets, Current $8,936,600,000 USD 31%
Deferred Income Tax Assets, Net $312,400,000 USD -68%
Property, Plant and Equipment, Net $3,075,700,000 USD -4.2%
Operating Lease, Right-of-Use Asset $330,500,000 USD -13%
Intangible Assets, Net (Excluding Goodwill) $9,331,900,000 USD -4.8%
Goodwill $6,490,700,000 USD 0.08%
Other Assets, Noncurrent $729,700,000 USD 16%
Assets $29,207,500,000 USD 3.2%
Accounts Payable, Current $413,100,000 USD -2.3%
Employee-related Liabilities, Current $310,700,000 USD 7.6%
Liabilities, Current $3,290,000,000 USD -39%
Accrued Income Taxes, Noncurrent $164,700,000 USD 1.7%
Deferred Income Tax Liabilities, Net $358,100,000 USD -59%
Operating Lease, Liability, Noncurrent $305,000,000 USD -15%
Other Liabilities, Noncurrent $761,800,000 USD 2.4%
Liabilities $11,000,000,000 USD -8%
Accumulated Other Comprehensive Income (Loss), Net of Tax $214,800,000 USD -47%
Retained Earnings (Accumulated Deficit) $20,601,600,000 USD 8.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $18,207,500,000 USD 11%
Liabilities and Equity $29,207,500,000 USD 3.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $259,300,000 USD -53%
Net Cash Provided by (Used in) Financing Activities $23,000,000 USD 95%
Net Cash Provided by (Used in) Investing Activities $47,300,000 USD 28%
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Shares, Issued 169,500,000 shares 0.47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3,862,800,000 USD 127%
Deferred Tax Assets, Valuation Allowance $1,013,700,000 USD -21%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability $420,900,000 USD -14%
Depreciation $277,600,000 USD 0.07%
Payments to Acquire Property, Plant, and Equipment $37,100,000 USD -19%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $1,539,400,000 USD -5.5%
Lessee, Operating Lease, Liability, to be Paid $504,700,000 USD -15%
Property, Plant and Equipment, Gross $5,852,100,000 USD 2.4%
Operating Lease, Liability, Current $86,400,000 USD -4.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two $88,500,000 USD -7.9%
Lessee, Operating Lease, Liability, to be Paid, Year One $103,400,000 USD -2.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) $27,800,000 USD -170%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $83,800,000 USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year Three $88,300,000 USD 5.7%
Deferred Tax Assets, Operating Loss Carryforwards $1,357,200,000 USD -20%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 8,000,000 shares 0%
Unrecognized Tax Benefits $186,300,000 USD 7.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four $50,200,000 USD -42%
Additional Paid in Capital $797,700,000 USD 63%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $135,700,000 USD 23%
Depreciation, Depletion and Amortization $183,200,000 USD 24%
Deferred Tax Assets, Net of Valuation Allowance $2,933,000,000 USD 0.02%
Share-based Payment Arrangement, Expense $301,500,000 USD -9.9%
Interest Expense $260,000,000 USD -0.69%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%